$1.74
0.052.96%
Last update: Nov 10, 1:43 AM
Evotec SE
EVONASDAQ
Evotec fell 41.8% from $2.99 to $1.74, behind the S&P 500's +10.5%. Its worst day was Jul 13 (−12.7%), and its low came Oct 13 at $1.35.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Evotec closed at its highest level of the year, 29.4% above where the year started.
+2.9% · S&P 500 −0.2%
Evotec shares rose 10.8%, while the S&P 500 fell 0.8%.
+10.8% · S&P 500 −0.8%
Story events cover the past 12 months · Times ET
Evotec launches transformation plan, targeting 75 million euros in savings by 2027 and revenue above 1 billion euros by 2030.
−11.9% · S&P 500 −0.2%
EPS of $0.05 beat the $0.02 estimate on $294.9M revenue (est. $253.3M); FY revenue guidance of $814.9M–$908.0M against the $957.5M consensus.
+4.3% · S&P 500 +2.5%
EPS of $-0.40 missed the $0.08 estimate on $183.4M revenue (est. $197.2M); FY revenue guidance of $819.7M–$913.4M against the $870.9M consensus.
+1.2% · S&P 500 +1.4%
Evotec SE (NASDAQ:EVO) (Frankfurt Prime Standard: EVT) today announced preliminary unaudited financial results for the second quarter and first half of 2026 and updated its full-year 2026 outlook.
−12.7%, the year's worst day · S&P 500 −0.8%
EPS of $-0.15 missed the $-0.06 estimate on $166.8M revenue (est. $212.4M); FY revenue guidance of $667.5M–$714.3M against the $673.8M consensus.
−7.8% · S&P 500 +0.7%
Evotec closed at its lowest level of the year, 55.0% below where the year started.
−1.8% · S&P 500 0.0%
EPS of $-0.09 beat the $-0.14 estimate on $189.8M revenue (est. $167.1M); FY revenue guidance of $656.0M–$702.0M against the $682.0M consensus.
+13.1%, the year's best day · S&P 500 −4.4%
Where it ended: a close of $1.74 on Nov 9, 2026.
Nothing in the past 12 months.
All EVO dividend historyChart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for EVO and SPY from Benzinga historical bars. Not investment advice.
